Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for donors ferres
Your search for Dolors Ferrés retrieved no results
[Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
Ferrés M, Nervi B, Ramírez P. Ferrés M, et al. Rev Chilena Infectol. 2012 Sep;29 Suppl 1:S23-8. doi: 10.4067/S0716-10182012000500004. Rev Chilena Infectol. 2012. PMID: 23282552 Free article. Review. Spanish.
The severity of the complications are mainly associated with the type of transplant and immune status against the virus of the transplant donor and the transplant recipient. It is important to prevent exposure, using safe blood transfusion CMV seronegative donors (B …
The severity of the complications are mainly associated with the type of transplant and immune status against the virus of the transplant …
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
Balcells ME, Rojas L, Le Corre N, Martínez-Valdebenito C, Ceballos ME, Ferrés M, Chang M, Vizcaya C, Mondaca S, Huete Á, Castro R, Sarmiento M, Villarroel L, Pizarro A, Ross P, Santander J, Lara B, Ferrada M, Vargas-Salas S, Beltrán-Pavez C, Soto-Rifo R, Valiente-Echeverría F, Caglevic C, Mahave M, Selman C, Gazitúa R, Briones JL, Villarroel-Espindola F, Balmaceda C, Espinoza MA, Pereira J, Nervi B. Balcells ME, et al. PLoS Med. 2021 Mar 3;18(3):e1003415. doi: 10.1371/journal.pmed.1003415. eCollection 2021 Mar. PLoS Med. 2021. PMID: 33657114 Free PMC article. Clinical Trial.
The main limitation of this study is the lack of statistical power to detect a smaller but clinically relevant therapeutic effect of CP, as well as not having confirmed neutralizing antibodies in donor before plasma infusion. CONCLUSIONS: In the present study, we failed to …
The main limitation of this study is the lack of statistical power to detect a smaller but clinically relevant therapeutic effect of CP, as …
One hundred years and still counting: the story of NEF--yesterday, today, and tomorrow.
Bowar-Ferres SL, Fitzpatrick ML, McClure ML. Bowar-Ferres SL, et al. Nurs Adm Q. 2014 Oct-Dec;38(4):332-9. doi: 10.1097/NAQ.0000000000000060. Nurs Adm Q. 2014. PMID: 25208153
Funds raised currently are largely from Board members, individual donors, modest foundational support, and a number of bequests. As the nursing population grows older, the potential for bequests or planned giving becomes a realistic goal. ...
Funds raised currently are largely from Board members, individual donors, modest foundational support, and a number of bequests. As t …
A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus.
Vial PA, Valdivieso F, Calvo M, Rioseco ML, Riquelme R, Araneda A, Tomicic V, Graf J, Paredes L, Florenzano M, Bidart T, Cuiza A, Marco C, Hjelle B, Ye C, Hanfelt-Goade D, Vial C, Rivera JC, Delgado I, Mertz GJ; Hantavirus Study Group in Chile. Vial PA, et al. Antivir Ther. 2015;20(4):377-86. doi: 10.3851/IMP2875. Epub 2014 Oct 15. Antivir Ther. 2015. PMID: 25316807 Clinical Trial.
We designed an open trial to explore safety and efficacy and evaluate pharmacokinetics of immune plasma as a treatment strategy for this disease. METHODS: We performed plasmapheresis on donors at least 6 months after HCPS and measured NAb titres through a focus-reduction n …
We designed an open trial to explore safety and efficacy and evaluate pharmacokinetics of immune plasma as a treatment strategy for this dis …